IC50: 40 nM (recombinant SHP-1)[1]
[1]. Kundu S, et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J Immunol. 2010 Jun 1;184(11):6529-36.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!